retatrutide triple agonist gip glp-1 glucagon phase 3 2025 A review of an investigational drug retatrutide, a novel agent for the treatment of obesity | European Journal of Clinical Pharmacology retatrutide triple agonist glp-1 gip
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11



























